EGF and cancer: Targeting ligands such as folic acid, biotin, RGD peptides, EGF-binding peptides, carbohydrates, and amino acids have been widely employed to exploit overexpressed receptors on cancer cells, dramatically improving selective uptake, intracellular accumulation, and therapeutic efficacy.